| scholarly article | Q13442814 |
| P2093 | author name string | Song Gao | |
| Jian Gao | |||
| Huimin Wang | |||
| Song Zhang | |||
| Xiao Li | |||
| Bei Lin | |||
| Juanjuan Liu | |||
| Mingzi Tan | |||
| Yingying Hao | |||
| Danye Zhang | |||
| P2860 | cites work | The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors | Q24631515 |
| Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells | Q24657020 | ||
| Clear cell carcinoma of the ovary: a review of the literature | Q28265125 | ||
| Organizing the cell cortex: the role of ERM proteins | Q28277373 | ||
| Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin | Q28574426 | ||
| Cancer stem cells in bladder cancer: a revisited and evolving concept | Q33639897 | ||
| Correlation of CD44v6 expression with ovarian cancer progression and recurrence | Q34658867 | ||
| Macrophages as mediators of tumor immunosurveillance | Q36823555 | ||
| CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis | Q37118119 | ||
| Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway | Q37368626 | ||
| Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay | Q39162225 | ||
| HGF-promoted motility in primary human melanocytes depends on CD44v6 regulated via NF-kappa B, Egr-1, and C/EBP-beta | Q39720254 | ||
| Ezrin mediates c-Myc actions in prostate cancer cell invasion. | Q39763221 | ||
| Identification of gastric cancer stem cells using the cell surface marker CD44. | Q39856772 | ||
| Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines | Q39979670 | ||
| CD44v6 promotes proliferation by persisting activation of MAP kinases. | Q40422436 | ||
| Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells | Q40495959 | ||
| Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration | Q40802553 | ||
| CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells | Q43753497 | ||
| HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells | Q43876212 | ||
| c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion | Q64377234 | ||
| Clear cell carcinoma of the ovary: characterization of its CD44 isoform repertoire | Q73153329 | ||
| CD44 splice variant expression in clear cell carcinoma of the ovary | Q77593189 | ||
| CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins | Q78257412 | ||
| Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease | Q80356660 | ||
| Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient | Q83818621 | ||
| CD47 regulation of epithelial cell spreading and migration, and its signal transduction | Q83999811 | ||
| The role of CD44+/CD24-/low biomarker for screening, diagnosis and monitoring of breast cancer | Q86998073 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | clear cell carcinoma | Q18556242 |
| P304 | page(s) | 3391-3404 | |
| P577 | publication date | 2015-02-04 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Expression and significance of CD44, CD47 and c-met in ovarian clear cell carcinoma | |
| P478 | volume | 16 |
| Q55267167 | ADH1B promotes mesothelial clearance and ovarian cancer infiltration. |
| Q90655642 | Activation of phagocytosis by immune checkpoint blockade |
| Q89820636 | Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis |
| Q47144091 | Annexin A4 fucosylation enhances its interaction with the NF-kB p50 and promotes tumor progression of ovarian clear cell carcinoma |
| Q93189835 | CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1 |
| Q54256362 | CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells. |
| Q26781215 | Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies |
| Q90629204 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death |
| Q91967424 | Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma |
| Q38982422 | Immunogenic cell death in cancer and infectious disease |
| Q28386858 | Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation |
| Q57065041 | METCAM/MUC18 Decreases the Malignant Propensity of Human Ovarian Carcinoma Cells |
| Q47843948 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. |
| Q33850271 | Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma |
| Q37020135 | Positive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysis |
| Q26795466 | Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer |
| Q57493808 | Prognostic impact of high c-Met expression in ovarian cancer: a meta-analysis |
| Q26796554 | Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis |
| Q38763283 | Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment |
| Q38718295 | Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies. |
| Q33588273 | Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth |
| Q38809675 | Small molecule inhibitor of c-Met (PHA665752) suppresses the growth of ovarian cancer cells and reverses cisplatin resistance |
| Q42533198 | Synthesis of a hexasaccharide partial sequence of hyaluronan for click chemistry and more |
| Q98164379 | Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence |
| Q64065739 | Targeting CD47 in Sézary syndrome with SIRPαFc |
| Q38807463 | The CD47 "don't eat me signal" is highly expressed in human ovarian cancer |
| Q38824065 | The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer |
| Q37564029 | The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis |
| Q51703765 | The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis. |
| Q37472110 | c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma |
Search more.